Dont think it is anything new. Article was first received 16 April 2021, revised 17 June 2021, received revised version 20 June 2021 and available online 23 June 2021. My guess is this is just the detailed version of news released previously in public. Still good news.

This whole Celectra hold has seemed odd from the start. First of all, to my knowledge no-one has stated what the problem with Celectra is and what shortfalls need to be met? Why has INO never pointed this out in public? However the most odd thing about it is why is the hold just applied to the 4800 trial? Why has it not been held back on other INO trials that are farther along already in Phase 3? Just a few questions if anybody knows the answers.

Can you please supply a source that states Cellectra is disapproved. If that is opinion it should be stated as opinion.

You know, someday there is going to be some news on INO and it will be really good or will be really bad. Either way this thing is winding up really tight and when it goes it will be dramatic. Problem is at this point I have no idea which it is going to be. I was very optimistic for a long time but this prolonged silence is beginning to really worry me. Biggest fear is another dilution to finance ongoing projects. Plenty of cash now but the burn rate will accelerate and won't last long. This is just venting some frustration.

Got anything new? You sound like a broken record. Try being creative.

Looks like they were trying (successfully) to drive it down premarket but plans went off tracks when market opened and everybody started covering.

INO moving down 3-4% premarket on 40,000 shares traded. Smells like something fishy going on here.

You really should try doing a little research before you make these proclamations. Just makes you look foolish. INO has a big pipeline with lots of potential. Far from a sure thing but enough to keep people who can read interested. That is why we are trading at $9+ currently. If there was truly ZERO in the pipeline INO would already be back below $2. Think about it.

Maybe he means it in nice way!

Sign me up for that!!

Kim holding out for $30 billion. Thats translates to about $140/ share. That would be a good starting point for the bidding to begin after 4800 phase 3 completed soon and the cancer vaccines start falling in line.

I always feel better after my Daily Morning Dump.Sets the stage for a productive day. Glad we got this over this morning.

Same news from yesterday. But still good.

I had my daily dump earlier this morning. It was great!

Unfortunately only moderators can remove their own sticky. That is the problem with letting anyone be a moderator.

There is additional information if you read a little closer.

INOVIO Expands Partnership with Advaccine to Conduct Global Phase 3 Efficacy Trial of COVID-19 DNA Vaccine Candidate, INO-4800

June 08, 2021
Download PDF Format (opens in new window)
Phase 3 efficacy trial planned to commence this summer in areas of the world underserved by vaccines
News follows recently announced Phase 2 data, which showed INO-4800 to be well-tolerated and immunogenic in all age groups


https://ir.inovio.com/news-releases/news-releases-details/2021/INOVIO-Expands-Partnership-with-Advaccine-to-Conduct-Global-Phase-3-Efficacy-Trial-of-COVID-19-DNA-Vaccine-Candidate-INO-4800/default.aspx

Last 10 days has been a steady increase from about $6.25 up to about $7.25 a share on relatively low volume. I think the big guys have already made their purchases and little investors are showing confidence with steady slow buying and little selling. At this point everyone is holding, waiting for developments to be revealed in the near future. As pointed out by other posters there are numerous developments in line to come out soon. If these don't start to appear it could be a rough time for INO. However, if good news is released it could go like a coiled spring. I still favor the coiled spring.

SOS! Cant you come up with something new? Try a little creativity. Or even better, some new facts.

INOVIO Announces Appointment Of Roger Dansey, M.D., to its Board of Directors
8:00 AM ET 5/17/21 | Dow Jones

Another shady character takes appointment to the BOD. Right MG?

PLYMOUTH MEETING, Pa., May 17, 2021 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated diseases, today announced the appointment of Roger D. Dansey, M.D. to its Board of Directors. The appointment adds extensive expertise in drug development to the INOVIO Board as the company strengthens its focus on its late stage product development programs. Currently the Chief Medical Officer at Seagen (formerly Seattle Genetics), Dr. Dansey has played a central role in Seagen's efforts to become a globally recognized, multi--product oncology company.

Dr. Dansey previously served as the Therapeutic Area Head for Late-Stage Oncology at Merck & Co., Inc., where he oversaw registration efforts for Keytruda(R) (pembrolizumab) across multiple tumor types. Earlier in his career, he was the Vice President of Oncology Clinical Research at Gilead Sciences and the Global Development Lead for Xgeva(R) (denosumab) at Amgen, where he held multiple roles in both oncology and hematology. Dr. Dansey holds an M.D. from the University of Witwatersrand in Johannesburg, South Africa.

Sounds reputable to me!

Hope that is "reputable" enough for MG since he is the (self-proclaimed) expert on reputability.

The fake numbers remark was not aimed at you.

Don't need to. Wasn't touting a fake "prevailing sentiment".

Show me numbers behind this "prevailing sentiment". I don't think they exist, except in your mind. So far you make only one vague reference to who is this "prevailing sentiment". Takes more than one to be prevailing. You can talk about your sentiment or another persons sentiment but this does not make it prevailing. What you say is dishonest and misleading.

Speak for yourself. That sentiment does not prevail with me.

Nervous Nellies gave away their INO shares this AM in premarket focusing on facts and numbers they really didn't understand. Lot of sad people right now. Investors who can look forward and not focus on past issues presented by people with questionable motives recognize a bargain and are buying up shares in regular trade. Have no idea where we will end the day but still believe we have numerous positive information releases (not just 4800) pending and the long term trend will be upward. Personal opinion.

Plotkin is on the Inovio Scientific Advisory Board. Not sure he is talking about Inovio but he is a speaker.

Well, once you put the fire in your hair out and look back at this situation you will see it is not the great unexpected catastophe everyone is crying about. You could see months ago the US vaccine market was lost and the need for vaccines in general are diminishing. Was surprised the feds pulled back the allotted money though. Usually they hate admitting a mistake and don't really care about spending money. In the mean time the Asia vaccine developments continue and will proceed on for the global market. But as I have posted before, vaccines have never been a moneymaker and that is the reason big Pharma pays little attention to it.

The real value in this stock is in the cancer drugs in the pipeline which are soon to reach significant milestones. If these fall on their face then you will have something to cry about and admit defeat. Till then there is still unlimited potential and the game is a long way from over.

Yes, but I live under a very nice rock.

Well why don't you stop doing them!

Maybe phase 3 VGX 3100 cancer trial finishing up end of May might be a cusp? You have to admit that that could be a cusp. Still no money for a year or two under the best conditions but still a cusp.

First of all I am not a bag holder. Over the last 6-7 years I have held this stock I am up 80-90 percent, if I hadn't traded. With trading along the way buying and selling highs and lows I am up substantially higher. In fact this is probably my most productive stock in over 30 years of trading. I would only be a bag holder if I had listened to your advice. Secondly, I still believe in the technology and I believe this is just the beginning of great things. Too afraid to trade now because I don't want to miss the big gains. Phase 3 REVEAL 2 for VGX 3100 cervical cancer treatment is on the verge of completion estimated 30 MAY 21 (see my previous post) and this will be the game changer, not the COVID vaccine.

REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)

Reveal Phase 3 status updated April 6, 2021. Highlights put in by me.

Brief Summary:
HPV-303 is a prospective, randomized, double-blind, placebo-controlled phase 3 study of VGX-3100 delivered intramuscularly (IM) followed by electroporation (EP) delivered with CELLECTRA™ 5PSP in adult women with histologically confirmed high-grade squamous intraepithelial lesions (HSIL) (cervical intraepithelial neoplasia grade 2 [CIN2] or grade 3 [CIN3]) of the cervix, associated with HPV-16 and/or HPV-18.

Study Type : Interventional (Clinical Trial)
Estimated Enrollment : 198 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Randomized Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL
Actual Study Start Date : April 9, 2019
Estimated Primary Completion Date : April 30, 2021
Estimated Study Completion Date : May 30, 2021


https://clinicaltrials.gov/ct2/show/study/NCT03721978?term=Inovio+Pharmaceutical&recrs=ab&draw=2&rank=4

Not disappointing for me!!!

Another disappointment. I really thought that after the bonus awards that something significant was going to happen. But nothing really new was released. Most of the cc information was already in the system. No bombshells, just more 'things will happen in the next 3-6 months'. I still think that INO has a lot of potential but you better be wilingl to sit on this thing for another 1-2 years before any game changer is revealed.

SEC filings just published for stock issued to top management. Are these the P3 milestone benefits to management? Does this mean P3 has been approved?

Check INO site

http://ir.inovio.com/financials/default.aspx

INOVIO Announces First Subject Dosed in Phase 1B Clinical Trial for its DNA Vaccine Against Lassa Fever, INO-4500, in West Africa
February 23, 2021

http://ir.inovio.com/news-releases/news-releases-details/2021/INOVIO-Announces-First-Subject-Dosed-in-Phase-1B-Clinical-Trial-for-its-DNA-Vaccine-Against-Lassa-Fever-INO-4500-in-West-Africa/default.aspx

How do you know that? I sounds like an opinion. Everyone is entitled to an opinion but it needs to be stated as an opinion, not a fact.

You are beacon of knowledge and altruism. Sorry I didn't recognize this right off. I just figured you were a shorter or had some other ax to grind with INO.